PULSE BIOSCIENCES, INC. — Director's Dealing 2019

Jan 18, 2019

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Pulse Biosciences, Inc. (PLSE)
CIK: 0001625101
Period of Report: 2019-01-11

Reporting Person: Ebbers Ed (EVP & GM, Dermatology)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	40376	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$4.68	2026-07-13	Common Stock (56159)		Direct
Stock Option (right to buy)	$27.14	2027-02-15	Common Stock (30000)		Direct

Footnotes

F1: 10,863 shares are represented by restricted stock units ("RSUs"). Each RSU represents the Reporting Person's right to receive one share of Common Stock of the Issuer. Fifty percent (50%) of the RSUs will vest on June 1, 2019 and the remaining 50% will vest on June 1, 2021, subject to the Reporting Person's continued service through each vesting date.

F2: The original option was for 117,200 shares. The remaining unexercised shares subject to the option will vest in equal monthly installments and will be fully vested on July 11, 2020, subject to the Reporting Person's continued service through each vesting date.

F3: The shares subject to the option will vest in equal monthly installments over a four year period that began on February 15, 2017, subject to the Reporting Person's continued service through each vesting date.